Integrated Core Strategies (US) LLC 13D and 13G filings for MaxCyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-31 4:23 pm Sale |
2024-09-30 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 4,192,865 4.000% |
-1,556,150 (-27.07%) |
Filing |
| 2024-03-25 4:36 pm Purchase |
2024-03-19 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,749,015 5.500% |
736,732 (+14.70%) |
Filing |
| 2024-02-01 4:25 pm Sale |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,012,283 4.800% |
-758,611 (-13.15%) |
Filing |
| 2023-11-17 4:05 pm Purchase |
2023-11-08 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,770,894 5.600% |
5,770,894 (New Position) |
Filing |